D05.82
Other specified type of carcinoma in situ of left breast
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code D05.82 refers to a specific diagnosis involving an abnormal growth of cells in the left breast that are confined to their original location and have not invaded nearby tissues. This condition is classified as carcinoma in situ, indicating that the abnormal cells are non-invasive. Recognized as a precancerous state, this diagnosis requires careful assessment and management to prevent progression to invasive breast cancer. Patients diagnosed with D05.82 should work closely with their healthcare providers to understand their condition and explore appropriate options for monitoring and treatment.
Causes & Symptoms
Clinical Causes: Genetic predispositions and family history of breast cancer Hormonal factors influencing breast cell growth Environmental exposures to carcinogens Previous radiation therapy to the chest area Lifestyle factors such as alcohol consumption and obesity
Key Symptoms: Often no noticeable symptoms in early stages Palpable lumps or thickening in the breast tissue Changes in the appearance or size of the breast Nipple alterations, including discharge or inversion Skin changes such as redness or dimpling
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of imaging and tissue sampling including:
Treatment Protocols: The management plan for carcinoma in situ of the breast, including D05.82, depends on various factors such as size, location, and patient health. Typical treatment options include:
Clinical Advice & FAQs
Billing Guidance
Is D05.82 a billable ICD-10 code?
Yes, D05.82 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D05.82?
Clinical documentation must specify the nature of Other specified type of carcinoma in situ of left breast and any associated comorbidities for accurate reporting.
Cite this Clinical Reference